Organon & Co | OGN - Les Charges D'Exploitation

Prix De L'Action
6.35
Variation Quotidienne
0.02 0.32%
Mensuellement
-12.77%
Annuel
-58.62%
Q1 Prévisions
6.16




Les Charges D'Exploitation Changement Date
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Celltrion KRW 724.99B 6B 2025-09
Cspc Pharmaceutical CNY 5.4B 298.41M 2025-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 40.68M 5.56M 2025-09
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Glaxosmithkline GBP 7.77B 2.22B 2025-09
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Merck USD 10.16B 558M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Novartis USD 9.77B 401M 2025-09
Organigram Holdings CAD 108.11M 17.03M 2025-09
Organon & Co USD 906M 362M 2025-09
Ovoca Bio EUR 5.65M 3.45M 2022-06
Pharma Mar EUR 46.87M 7.24M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Sartorius EUR 693.1M 29.4M 2025-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tilray USD 237.52M 17.34M 2025-09